SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001493152-24-024598
Filing Date
2024-06-20
Accepted
2024-06-20 20:56:02
Documents
3
Period of Report
2024-06-17

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 7150
2 ex24.htm EX-24 11888
3 ex24_001.jpg GRAPHIC 22220
  Complete submission text file 0001493152-24-024598.txt   51308
Mailing Address 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 4475 EXECUTIVE DRIVE SUITE 200 SAN DIEGO CA 92121 858-794-9600
Calidi Biotherapeutics, Inc. (Issuer) CIK: 0001855485 (see all company filings)

IRS No.: 862967193 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 4475 EXECUTIVE DRIVE, SUITE 200 SAN DIEGO CA 92121
Business Address
Campbell Wendy Pizarro (Reporting) CIK: 0001990445 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40789 | Film No.: 241058188